Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA, 23andMe Open Up Market Pathway For DTC Genetics

This article was originally published in The Gray Sheet

Executive Summary

The Google-backed firm's carrier screening assay for a rare disease called Bloom syndrome is the first DTC genetic test to achieve sign off from FDA. More importantly, the marketing authority was awarded in a manner that could significantly streamline the path to market for future DTC carrier-screening assays.

Advertisement

Related Content

23andMe Opens Up FDA Pathway For DTC Genetic Predisposition Tests
Trump Meets With Two US FDA Commissioner Candidates; Third Still Lurking
Trump Meets With Two US FDA Commissioner Candidates; Third Still Lurking
Possible Trump FDA Commish Candidate Favors (Much) Lighter Touch
Possible Trump FDA Commish Candidate Favors (Much) Lighter Touch
Possible Trump FDA Commish Candidate Favors (Much) Lighter Touch
FDA Releases LDT Regulatory Framework, Notification Draft Guidances
FDA Comes Down Hard On 23andMe, Putting Consumer-Directed Genetic Testing On Notice
23andMe Launches TV Ad Campaign For DTC Gene Testing Service While Seeking 510(k)
FDA To Regulate Direct-To-Consumer Genetic Tests

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT034526

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel